181 related articles for article (PubMed ID: 24294178)
41. Utility of uroplakin II expression as a marker of urothelial carcinoma.
Tian W; Guner G; Miyamoto H; Cimino-Mathews A; Gonzalez-Roibon N; Argani P; Li X; Sharma R; Subhawong AP; Rezaei K; Bivalacqua TJ; Epstein JI; Bishop JA; Netto GJ
Hum Pathol; 2015 Jan; 46(1):58-64. PubMed ID: 25449628
[TBL] [Abstract][Full Text] [Related]
42. Specific heterodimer formation is a prerequisite for uroplakins to exit from the endoplasmic reticulum.
Tu L; Sun TT; Kreibich G
Mol Biol Cell; 2002 Dec; 13(12):4221-30. PubMed ID: 12475947
[TBL] [Abstract][Full Text] [Related]
43. Large scale purification and immunolocalization of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation.
Wu XR; Manabe M; Yu J; Sun TT
J Biol Chem; 1990 Nov; 265(31):19170-9. PubMed ID: 2229070
[TBL] [Abstract][Full Text] [Related]
44. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
[TBL] [Abstract][Full Text] [Related]
45. Directed differentiation of human induced pluripotent stem cells into mature stratified bladder urothelium.
Suzuki K; Koyanagi-Aoi M; Uehara K; Hinata N; Fujisawa M; Aoi T
Sci Rep; 2019 Jul; 9(1):10506. PubMed ID: 31324820
[TBL] [Abstract][Full Text] [Related]
46. Uroplakin 1b is critical in urinary tract development and urothelial differentiation and homeostasis.
Carpenter AR; Becknell MB; Ching CB; Cuaresma EJ; Chen X; Hains DS; McHugh KM
Kidney Int; 2016 Mar; 89(3):612-24. PubMed ID: 26880456
[TBL] [Abstract][Full Text] [Related]
47. Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas.
Moll R; Wu XR; Lin JH; Sun TT
Am J Pathol; 1995 Nov; 147(5):1383-97. PubMed ID: 7485401
[TBL] [Abstract][Full Text] [Related]
48. Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
Feil G; Maurer S; Nagele U; Krug J; Bock C; Sievert KD; Stenzl A
Eur Urol; 2008 May; 53(5):1066-72. PubMed ID: 17980954
[TBL] [Abstract][Full Text] [Related]
49. Urothelial papilloma of the bladder: a review of 34 de novo cases.
Magi-Galluzzi C; Epstein JI
Am J Surg Pathol; 2004 Dec; 28(12):1615-20. PubMed ID: 15577681
[TBL] [Abstract][Full Text] [Related]
50. A review of bovine urothelial tumours and tumour-like lesions of the urinary bladder.
Roperto S; Borzacchiello G; Brun R; Leonardi L; Maiolino P; Martano M; Paciello O; Papparella S; Restucci B; Russo V; Salvatore G; Urraro C; Roperto F
J Comp Pathol; 2010; 142(2-3):95-108. PubMed ID: 19818448
[TBL] [Abstract][Full Text] [Related]
51. Immunohistochemical analysis of uroplakins, urothelial specific proteins, in ovarian Brenner tumors, normal tissues, and benign and neoplastic lesions of the female genital tract.
Ogawa K; Johansson SL; Cohen SM
Am J Pathol; 1999 Oct; 155(4):1047-50. PubMed ID: 10514386
[TBL] [Abstract][Full Text] [Related]
52. A newly developed uroplakin II antibody with increased sensitivity in urothelial carcinoma of the bladder.
Hoang LL; Tacha DE; Qi W; Yu C; Bremer RE; Chu J; Haas TS; Cheng L
Arch Pathol Lab Med; 2014 Jul; 138(7):943-9. PubMed ID: 24978921
[TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of atypical papillary urothelial hyperplasia.
Swierczynski SL; Epstein JI
Hum Pathol; 2002 May; 33(5):512-7. PubMed ID: 12094376
[TBL] [Abstract][Full Text] [Related]
54. Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux.
Hu P; Deng FM; Liang FX; Hu CM; Auerbach AB; Shapiro E; Wu XR; Kachar B; Sun TT
J Cell Biol; 2000 Nov; 151(5):961-72. PubMed ID: 11085999
[TBL] [Abstract][Full Text] [Related]
55. Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 26 cases.
McKenney JK; Amin MB; Young RH
Mod Pathol; 2003 Jul; 16(7):623-9. PubMed ID: 12861056
[TBL] [Abstract][Full Text] [Related]
56. [Uroplakins as markers of diseases of the urinary system].
Lis J; Kątnik-Prastowska I; Tupikowski K; Matejuk A
Postepy Hig Med Dosw (Online); 2015 Jan; 69():98-113. PubMed ID: 25614678
[TBL] [Abstract][Full Text] [Related]
57. The Golgi complex: An organelle that determines urothelial cell biology in health and disease.
Kreft ME; Mironov AA; Hudoklin S
Histochem Cell Biol; 2022 Sep; 158(3):229-240. PubMed ID: 35773494
[TBL] [Abstract][Full Text] [Related]
58. Urothelial Differences in the Exstrophy-Epispadias Complex: Potential Implications for Management.
Kasprenski M; Michaud J; Yang Z; Maruf M; Benz K; Jayman J; Epstein J; Di Carlo H; Gearhart JP
J Urol; 2021 May; 205(5):1460-1465. PubMed ID: 33347773
[TBL] [Abstract][Full Text] [Related]
59. Expression of cytokeratin 20 redefines urothelial papillomas of the bladder.
Harnden P; Mahmood N; Southgate J
Lancet; 1999 Mar; 353(9157):974-7. PubMed ID: 10459907
[TBL] [Abstract][Full Text] [Related]
60. Uroplakins as markers of urothelial differentiation.
Sun TT; Liang FX; Wu XR
Adv Exp Med Biol; 1999; 462():7-18; discussion 103-14. PubMed ID: 10599409
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
